Farther Finance Advisors, LLC

Position in PFE — Pfizer Inc

CIK 1992825 SAN FRANCISCO, CA

Position in PFE

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$9,518,751

+$2,092,855 QoQ

Shares Held

395,297

+49.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#101

of 1,181 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. PFE ranks #6 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc.	120,685	$15,508,022
5	AMGN	Amgen Inc	34,711	$12,569,547
6	PFE	Pfizer Inc This page	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc.	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,518,751	395,297	+49.5%	Shares	Sole	2026-07-17
2026-03-31	$7,425,896	264,455	+19.8%	Shares	Sole	2026-04-07
2025-12-31	$5,497,272	220,774	+57.4%	Shares	Sole	2026-01-23
2025-09-30	$3,572,856	140,222	+3.5%	Shares	Sole	2025-10-14
2025-06-30	$3,284,495	135,499	+58.9%	Shares	Sole	2025-07-11
2025-03-31	$2,161,248	85,290	+44.1%	Shares	Sole	2025-04-14
2024-12-31	$1,570,443	59,195	-3.1%	Shares	Sole	2025-02-10
2024-09-30	$1,768,378	61,105	+11.4%	Shares	Sole	2024-10-29
2024-06-30	$1,534,507	54,843	+28.4%	Shares	Sole	2024-07-31
2024-03-31	$1,185,258	42,712	+12.7%	Shares	Sole	2024-05-14
2023-12-31	$1,090,651	37,883	+46.3%	Shares	Sole	2024-02-15
2023-09-30	$858,638	25,886	+46.4%	Shares	Sole	2023-11-14
2023-06-30	$648,502	17,680	+15.0%	Shares	Sole	2024-05-14
2023-03-31	$627,422	15,378	+93.3%	Shares	Sole	2024-05-14
2022-12-31	$407,716	7,957	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.